| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0094 | 0.8 |